Accentia Biopharmaceuticals to sell assets of Analytica International to LA-SER Alpha Group - MarketLine Financial Deals

Accentia Biopharmaceuticals to sell assets of Analytica International to LA-SER Alpha Group

Accentia Biopharmaceuticals to sell assets of Analytica International to LA-SER Alpha Group - MarketLine Financial Deals
Accentia Biopharmaceuticals to sell assets of Analytica International to LA-SER Alpha Group
Published Nov 07, 2011
2 pages — Published Nov 07, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Accentia Biopharmaceuticals, Inc. has entered into an agreement to sell the assets of Analytica International, Inc., a US-based healthcare economics consulting firm, to LA-SER Alpha Group Sarl.

  
Source:
Document ID
MA86564_111109
Country
Country
Ticker
ABPI=US
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Accentia Biopharmaceuticals to sell assets of Analytica International to LA-SER Alpha Group" Nov 07, 2011. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Accentia-Biopharmaceuticals-to-sell-assets-of-Analytica-International-to-LA-SER-Alpha-Group-2052-72386>
  
APA:
MarketLine Financial Deals. (2011). Accentia Biopharmaceuticals to sell assets of Analytica International to LA-SER Alpha Group Nov 07, 2011. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Accentia-Biopharmaceuticals-to-sell-assets-of-Analytica-International-to-LA-SER-Alpha-Group-2052-72386>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.